THE ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS COMORBIDITY AND THE SEVERITY OF ACUTE EXACERBATIONS IN COPD PATIENTS (2015–2025)
Keywords:
Chronic Obstructive Pulmonary Disease (COPD), , Type 2 Diabetes Mellitus,, Comorbidity, , Acute Exacerbation, , SeverityAbstract
Comorbid type 2 diabetes mellitus is frequently found in patients with chronic obstructive pulmonary disease (COPD) and is suspected to worsen the condition during acute exacerbations. This study aimed to determine the relationship between type 2 diabetes mellitus comorbidity and the severity of acute exacerbations in COPD patients. This study was a descriptive analytic study with a retrospective approach and a cross-sectional design using medical record data of COPD patients at RSD K.R.M.T. Wongsonegoro from 2015–2025. A total of 27 patients were included using total sampling. Data were analyzed using univariate and bivariate analysis with the Fisher Exact test. The results showed that most patients were ≥ 60 years old and male. Most patients had uncontrolled type 2 diabetes mellitus. The distribution of exacerbation severity consisted of 12 mild cases, 14 moderate cases, and 1 severe case. Bivariate analysis showed a p-value of 0.449, indicating no significant relationship between type 2 diabetes mellitus comorbidity and the severity of COPD exacerbations.Type 2 diabetes mellitus comorbidity in COPD patients was more frequently found in mild to moderate exacerbations than in severe exacerbations
References
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., et al. (2023). Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharmacotherapy, 168, 115734.
Bitar, A. N., Ghoto, M. A., Dayo, A., Arain, M. I., & Parveen, R. (2021). Pathophysiological Correlation between Diabetes Mellitus Type - II and Chronic Obstructive Pulmonary Diseases. Journal of Pharmaceutical Research International, 16(01), 41–48.
Cazzola, M., Rogliani, P., Ora, J., Calzetta, L., Lauro, D., & Matera, M. G. (2023). Hyperglycaemia and Chronic Obstructive Pulmonary Disease. Diagnostics, 13(1), 1–13.
Chakrabarti, B., Angus, R. M., Agarwal, S., Lane, S., & Calverley, P. M. A. (2009). Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD. Thorax, 64(10), 857–862.
Chandrasekaran, P., & Weiskirchen, R. (2024). The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. International Journal of Molecular Sciences, 25(3), 1882.
Chen, G., Lin, Q., Zhuo, D., & Cui, J. (2022). Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 17, 2453–2459.
del Pino-Sedeño, T., González de León, B., Pérez Martín, E. F., Martín Gandolfo, A. M., Estupiñán Ramírez, M., Redondo, M., et al. (2020). Relationship between glycemic control and chronic obstructive pulmonary disease in patients with type 2 diabetes: A nested case-control study. Primary Care Diabetes, 14(6), 729–735.
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021). Emerging Targets in Type 2 Diabetes and Diabetic Complications. Advanced Science, 8(18), 1–23.
Dinas Kesehatan Provinsi Jawa Tengah. (2018). Profil Kesehatan Provinsi Jawa Tengah 2018. Semarang: Dinas Kesehatan Provinsi Jawa Tengah.
Fauci, J., Hauser, K., & Loscalzo, L. (2018). Harrison’s Principles of Internal Medicine (20th ed.). New York: McGraw-Hill.
Halpin, D. M. G., & CC. (2025). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Fontana: Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Hardiyanti, T., Yasin, N. M., & Andayani, T. M. (2021). Pengaruh Readmisi Terhadap Biaya pada Pasien PPOK Eksaserbasi Akut dan Faktor-Faktor yang Mempengaruhinya. Majalah Farmaseutik, 17(3), 398–405.
Harreiter, J., & Roden, M. (2023). Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023). Wiener klinische Wochenschrift, 135(S1), 7–17.
Hattiholi, J., Patil, B., Kandavel, G. S., Gautam, S., Gaude, G. S., & Pujar, K. K. (2023). Effect of Hyperglycemia on the Duration of Hospital Stay and Rate of Mortality in Patients of Chronic Obstructive Pulmonary Disease in Acute Exacerbation: A 1-year Hospital-based Observational Study. Indian Journal of Chest Diseases and Allied Sciences, 64(4), 253–257.
International Diabetes Federation. (2024). IDF Diabetes Atlas: Diabetes around the world in 2024. Brussels: International Diabetes Federation.
Kalyani, K., Reddy, C. R., & Kumar, M. M. (2023). Prospective Study of Hyperglycemia and Its Impact on The Causation of Severe Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients Attending a Tertiary Care Hospital. Journal of Applied Pharmaceutical Research, 11(5), 9–14.
Kassem, S., Zaina, A., Stein, N., & Naoum, I. (2025). Diabetes Control and Clinical Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation. Diabetology, 6(7), 1–10.
Kementerian Kesehatan Republik Indonesia. (2019). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/687/2019 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Penyakit Paru Obstruktif Kronik. Jakarta: Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. (2020). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/603/2020 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Diabetes Melitus Tipe 2 Dewasa. Jakarta: Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. (2023). Survei Kesehatan Indonesia Dalam Angka. Jakarta: Kementerian Kesehatan Republik Indonesia.
Lazarinis, N., Fouka, E., Linden, A., & Bossios, A. (2024). Small Airways Disease in Chronic Obstructive Pulmonary Disease. Expert Review of Respiratory Medicine, 18(7), 539–552.
Li, C. L., & Liu, S. F. (2024). Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives. International Journal of Molecular Sciences, 25(13), 7347.
Lin, L., Shi, J., Kang, J., & Wang, Q. (2021). Analysis of Prevalence and Prognosis of Type 2 Diabetes Mellitus in Patients With Acute Exacerbation of COPD. BMC Pulmonary Medicine, 21, 1–8.
MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., et al. (2021). Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology, 26(6), 532–551.
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., et al. (2025). Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. International Journal of Molecular Sciences, 26(3), 1–21.
Naeem, S., Wang, F., Mubarak, R., Shen, H., Li, X., Mommers, I., et al. (2025). Mapping the Global Distribution, Risk Factors, and Temporal Trends of COPD Incidence and Mortality (1990–2021): Ecological Analysis. BMC Medicine, 23(1), 1–14.
Nadapdap, F. M., Gultom, Y. B., & Sitepu, S. (2024). Hubungan Diabetes Melitus Tipe 2 dengan Derajat Obstruksi Penyakit Paru Obstruktif Kronik (PPOK) di RS. Royal Prima Periode 2022-2023. Ranah Research: Journal of Multidisciplinary Research and Development, 7(1), 545–552.
Nasri, A., Foisset, F., Ahmed, E., Lahmar, Z., Vachier, I., Jorgensen, C., et al. (2021). Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease. Cells, 10(12), 3467.
Pangaribuan, M., Yunus, F., Damayanti, T., & Rochsismandoko, R. (2020). The Prevalence of Diabetes Mellitus in Chronic Obstructive Pulmonary Disease Patients. Jurnal Respirologi Indonesia, 40(1), 48–57.
Park, S. S., Perez, J. L. P., Gandara, B. P., Agudelo, C. W., Ortega, R. R., Ahmed, H., et al. (2022). Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD? Medicina, 58(4), 1–23.
Perhimpunan Dokter Paru Indonesia. (2023). Pedoman Diagnosis dan Penatalaksanaan PPOK di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia.
Perkumpulan Endokrinologi Indonesia. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Jakarta: PB PERKENI.
Shakeel, I., Ashraf, A., Afzal, M., Sohal, S. S., Islam, A., Kazim, S. N., et al. (2023). The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics. Oxidative Medicine and Cellular Longevity, 2023, 1–19.
Tandon, S., Pawar, D., & Nagdeote, S. T. (2021). Blood Glucose Level and Outcomes in COPD Exacerbations. Journal of Medical Science and Clinical Research, 4(7), 4–7.
Tayal, D., Jain, P., Bhardwaj, M., & Sharma, A. (2024). Diabetes Mellitus in Acute Exacerbation of Chronic Obstructive Pulmonary Disease – The Tip of The Iceberg. Journal of Clinical and Diagnostic Research, 18(2), 94–98.
Uzokov, J., Alyavi, A., & Karimov, B. (2016). Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease. European Respiratory Journal, 48, PA3776.
World Health Organization. (2024). Chronic Obstructive Pulmonary Disease (COPD). Geneva: World Health Organization.
Xu, J., Zeng, Q., Li, S., Su, Q., & Fan, H. (2024). Inflammation mechanism and research progress of COPD. Frontiers in Immunology, 15, 1–11.
Zhao, G., Li, X., Lei, S., Zhao, H., Zhang, H., & Li, J. (2022). Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Oncology, 12, 1–14
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aslani threestianasari, Faradiba Aliyya Iklima, Susilo Budi Pratama (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
